• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用纳米囊泡系统增强昂丹司琼经皮传递:制备、表征、优化及体外渗透研究-Box-Cox 变换实例。

Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt.

Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University, Egypt.

出版信息

Eur J Pharm Sci. 2018 Mar 30;115:352-361. doi: 10.1016/j.ejps.2018.01.044. Epub 2018 Jan 31.

DOI:10.1016/j.ejps.2018.01.044
PMID:29407555
Abstract

This study aimed to formulate suitable nanovesicles (NVs) for transdermal delivery of Ondansetron. It also illustrated a practical example for the importance of Box-Cox transformation. A 2 full factorial design was used to enable testing transfersomes, ethosomes, and transethosomes of Ondansetron simultaneously. The independent variables (IVs) studied were sodium taurocholate amount, ethanol volume in hydration medium and sonication time. The studied dependent variables (DVs) were: particle size (PS), zeta potential (ZP) and entrapment efficiency (EE). Polynomial equations were used to study the influence of IVs on each DV. Numerical multiple response optimization was applied to select an optimized formula (OF) with the goals of minimizing PS and maximizing ZP absolute value and EE. Box-Cox transformation was adopted to enable modeling PS raised to the power of 1.2 with an excellent prediction R of 1.000. ZP and EE were adequately represented directly with prediction R of 0.9549 and 0.9892 respectively. Response surface plots helped in explaining the influence of IVs on each DV. Two-sided 95% prediction interval test and percent deviation of actual values from predicted ones proved the validity of the elucidated models. The OF was a transfersomal formula with desirability of 0.866 and showed promising results in ex-vivo permeation study.

摘要

本研究旨在为昂丹司琼的透皮给药构建合适的纳米囊(NVs)。它还说明了 Box-Cox 变换的重要性的实际示例。采用 2 全因子设计来同时测试昂丹司琼的传递体、醇质体和转醇质体。研究的自变量(IVs)为牛磺胆酸钠的量、水合介质中的乙醇体积和超声时间。研究的因变量(DVs)为:粒径(PS)、Zeta 电位(ZP)和包封效率(EE)。多项式方程用于研究 IVs 对每个 DV 的影响。数值多响应优化用于选择具有最小 PS 和最大 ZP 绝对值和 EE 的目标的优化配方(OF)。采用 Box-Cox 变换来对 PS 进行 1.2 次幂建模,具有出色的预测 R 为 1.000。ZP 和 EE 可以直接通过预测 R 为 0.9549 和 0.9892 来充分表示。响应面图有助于解释 IVs 对每个 DV 的影响。双向 95%预测区间测试和实际值与预测值的百分比偏差证明了所阐明模型的有效性。OF 是一种传递体配方,其适宜性为 0.866,并在体外渗透研究中显示出有希望的结果。

相似文献

1
Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example.采用纳米囊泡系统增强昂丹司琼经皮传递:制备、表征、优化及体外渗透研究-Box-Cox 变换实例。
Eur J Pharm Sci. 2018 Mar 30;115:352-361. doi: 10.1016/j.ejps.2018.01.044. Epub 2018 Jan 31.
2
Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.盐酸昂丹司琼经双分子层囊泡系统的透皮给药:体外、离体和体内特征研究。
AAPS PharmSciTech. 2018 Jul;19(5):2276-2287. doi: 10.1208/s12249-018-1019-y. Epub 2018 May 29.
3
Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.载丹皮酚传递体作为透皮给药载体的评价
Eur J Pharm Sci. 2017 Mar 1;99:240-245. doi: 10.1016/j.ejps.2016.12.026. Epub 2016 Dec 28.
4
Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.组合混合-工艺变量方法:一种用于纳米囊泡系统优化的合适统计工具。
Expert Opin Drug Deliv. 2016 Jun;13(6):777-88. doi: 10.1517/17425247.2016.1166202. Epub 2016 Apr 4.
5
Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin.用于增强克林霉素经皮递送的传递体纳米颗粒。
AAPS PharmSciTech. 2016 Oct;17(5):1067-74. doi: 10.1208/s12249-015-0441-7. Epub 2015 Oct 28.
6
Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.采用 Box-Behnken 统计设计研制并优化硝苯地平的纳米乳凝胶制剂以增强其经皮渗透。
Drug Dev Ind Pharm. 2020 Feb;46(2):329-342. doi: 10.1080/03639045.2020.1721527. Epub 2020 Feb 5.
7
Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation.双分子层囊泡作为有前途的纳米囊泡载体用于改善经皮给药:构建、体外优化、体外渗透和体内评价。
Int J Nanomedicine. 2020 Dec 8;15:9783-9798. doi: 10.2147/IJN.S278688. eCollection 2020.
8
Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.用于透皮递送奥美沙坦酯的新型软纳米载体的设计、配方及优化:体外表征与体内药代动力学评估
Int J Pharm. 2016 May 30;505(1-2):147-58. doi: 10.1016/j.ijpharm.2016.03.030. Epub 2016 Mar 19.
9
Nano-transfersomes as a novel carrier for transdermal delivery.纳米转脂体作为一种新型经皮给药载体。
Int J Pharm. 2013 Sep 15;454(1):367-80. doi: 10.1016/j.ijpharm.2013.07.031. Epub 2013 Jul 17.
10
Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.用于透皮给药的载盐酸雷洛昔芬纳米传递体的实验设计与优化
Int J Nanomedicine. 2014 Sep 12;9:4331-46. doi: 10.2147/IJN.S65408. eCollection 2014.

引用本文的文献

1
Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.载有特康唑的边缘活化混合弹性脂质体用于改善眼部真菌病中的角膜渗透:体外表征、统计优化、微生物学评估和体内评价。
Int J Pharm X. 2025 Apr 8;9:100333. doi: 10.1016/j.ijpx.2025.100333. eCollection 2025 Jun.
2
Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.探索载有抗真菌药物的前体脂质体增强真菌性角膜炎角膜渗透的潜力:从实验室表征到微生物学评估的全面研究
Int J Pharm X. 2025 Feb 24;9:100322. doi: 10.1016/j.ijpx.2025.100322. eCollection 2025 Jun.
3
Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis.微针穿刺介导的原位凝胶经皮递送载有依托度酸的聚乳酸-羟基乙酸共聚物纳米颗粒用于类风湿性关节炎的治疗
Pharmaceutics. 2024 Jun 21;16(7):844. doi: 10.3390/pharmaceutics16070844.
4
Nano-Formulation Approaches to Enhance Transdermal Drug Delivery-An Updated Review of Nanovesicular Carrier "Transethosomes".增强经皮给药的纳米制剂方法——纳米囊泡载体“转质体”的最新综述
Pharm Nanotechnol. 2024 May 15. doi: 10.2174/0122117385306281240427073651.
5
Capped flexosomes for prominent anti-inflammatory activity: development, optimization, and ex vivo and in vivo assessments.带帽的可变形囊泡具有显著的抗炎活性:开发、优化以及离体和在体评估。
Drug Deliv Transl Res. 2024 Sep;14(9):2474-2487. doi: 10.1007/s13346-024-01522-z. Epub 2024 Feb 5.
6
Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box-Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route.采用Box-Behnken设计法定制载利培酮的糖质体原位凝胶,经鼻内途径治疗精神分裂症诱导大鼠。
Pharmaceutics. 2023 Oct 24;15(11):2521. doi: 10.3390/pharmaceutics15112521.
7
Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast Cancer Cell Line.载有立方液晶纳米粒的口腔崩解片的制备与评价,用于提高辛伐他汀对MDA-MB-231乳腺癌细胞系的抗癌活性
Polymers (Basel). 2023 Apr 2;15(7):1774. doi: 10.3390/polym15071774.
8
Wound Healing Efficacy of Rosuvastatin Transethosomal Gel, I Optimal Optimization, Histological and In Vivo Evaluation.瑞舒伐他汀转质体凝胶的伤口愈合功效,I. 优化、组织学及体内评估
Pharmaceutics. 2022 Nov 19;14(11):2521. doi: 10.3390/pharmaceutics14112521.
9
Investigation of Alogliptin-Loaded In Situ Gel Implants by 2 Factorial Design with Glycemic Assessment in Rats.通过二因素设计对大鼠进行血糖评估来研究载有阿格列汀的原位凝胶植入物。
Pharmaceutics. 2022 Sep 5;14(9):1867. doi: 10.3390/pharmaceutics14091867.
10
Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene.脂质体作为番茄红素口服给药及体内抗菌活性调控的纳米平台
Pharmaceuticals (Basel). 2022 Aug 24;15(9):1043. doi: 10.3390/ph15091043.